https://www.selleckchem.com/pr....oducts/bay-1217389.h
05); or neonatal outcomes of Apgar score at 1 min ( = .88) or 5 min ( = .69), weight ( = .23), head circumference ( = .55), malnutrition ( = .27), hyperbilirubinemia (RR = 0.56, = .21), jaundice (RR = 1.21, = .84), respiratory distress (RR = 0.53, = .49), or tachypnea (RR = 0.40, = .42). With the limited high quality evidence available, retosiban demonstrates no clear benefit over placebo in the management of preterm labor. Nevertheless, its favorable safety profile, oral bioavailability, and novel mechanism of action and t
Like
Comment
Share
